返回 
加入收藏
基于成本-效益分析的医疗机构药学服务经济价值探讨
x
请在关注微信后，向客服人员索取文件
| 篇名： | 基于成本-效益分析的医疗机构药学服务经济价值探讨 |
| TITLE： | Discussion on economic value of pharmaceutical care in medical institutions based on cost-benefit analysis |
| 摘要： | 目的 系统评价采用成本-效益分析法评估医疗机构药学服务经济性的相关研究，以期为相关政策决策提供循证依据，并为今后开展药学服务经济性评价提供方法学参考。方法系统检索PubMed、Embase、Cochrane图书馆、中国生物医学文献数据库、万方数据、维普网、中国知网及相关网站中采用成本-效益分析法评估医疗机构药学服务经济性的研究，由2名研究人员根据“综合卫生经济评价报告标准清单”独立筛选研究，提取数据，并对纳入研究的质量进行评分和描述性系统评价。结果纳入了来自17个国家的46项研究，以美国（21.74％）、中国（19.57％）、法国（8.70％）居多。46篇文献的平均得分为14.30分，其中1篇文献的报告质量为优秀，5篇为良好，25篇为合格，15篇为不合格。有25项研究方案类型为前瞻性研究；纳入文献涉及的药学服务类型以药学监护居多（60.87％），其次是处方审核（23.91％），药物重整（8.70％）和药学门诊（6.52％）较少。纳入研究结果显示，药学服务的中位成本-效益比为5.05（3.08，11.28）。结论药学服务具有较好的经济价值，药师在节约医疗资源方面发挥了重要作用，但现有研究的设计水平和报告质量还有待改善。 |
| ABSTRACT： | OBJECTIVE To evalu ate relat ed researches about the cost- benefit of pharmaceutical care in medical institutions with cost- benefit analysis，in order to provide evidence-based basis for related policy decisions and provide methodological reference for the cost- benefit evaluation of pharmaceutical care in the future. METHODS Retrieved from PubMed ，Embase，the Cochrane Library ，CBM，Wanfang database ，VIP and CNKI ，cost-benefit analysis was used to evaluate the researches about the cost-benefit of pharmaceutical care in medical institutions. Two researchers independently screened the research and extracted data according to the “Consolidated Health Economic Evaluation Reporting Standards Checklist ”. The quality of included studies was scored and evaluated systematically. RESULTS A total of 46 studies from 17 countries were included. Most of them came from the United States （21.74％），China（19.57％）and France （8.70％）. Average score of 46 literature was 14.30，of which 1 literature was excellent ，5 literature were good ，25 literature were qualified and 14 literature were unqualified. There were 25 research protocols of prospective study type ；the type of pharmaceutical care involved mostly was pharmaceutical monitoring （60.87％）， followed by prescription review （23.91％），medication reconciliation （8.70％）and outpatient pharmacy （6.52％）were less. The median cost-benefit ratio of pharmaceutical care was 5.05 （3.08，11.28）. CONCLUSIONS Pharmaceutical care shows good economic value ，and pharmacists have played an important role in saving medical resources ，but the design level and report quality of the existing studies need to be improved. |
| 期刊： | 2022年第33卷第14期 |
| 作者： | 孔令希，王红梅，彭敏，邱峰，杨佳丹，单雪峰 |
| AUTHORS： | KONG Lingxi ，WANG Hongmei ，PENG Min，QIU Feng，YANG Jiadan，SHAN Xuefeng |
| 关键字： | 药学服务；成本；成本-效益；经济学评价；质量评估 |
| KEYWORDS： | pharmaceutical care ；cost；cost-benefit；economic evaluation ；quality evaluation |
| 阅读数： | 212 次 |
| 本月下载数： | 12 次 |
* 注：未经本站明确许可，任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作！
